Insulin Glulisine Recombinant — Active Pharmaceutical Ingredient

Insulin Glulisine Recombinant is an active pharmaceutical ingredient found in 2 FDA-approved drug products. Forms: INJECTABLE. Routes: INTRAVENOUS, SUBCUTANEOUS, SUBCUTANEOUS.

This content is for informational purposes only. Always consult a healthcare professional.

Insulin Glulisine Recombinant (2 brand names, 1 dosage form, 2 routes)

Available dosage forms: INJECTABLE.

Routes of administration: INTRAVENOUS, SUBCUTANEOUS, SUBCUTANEOUS.

Brand Names

  • APIDRA
  • APIDRA SOLOSTAR
⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.